Innovation: The Roadmap Ahead
Join four Chief Technology/Information/Infrastructure Officers in industries ranging from manufacturing and banking to healthcare to understand how technological advances will shape the innovation landscape for firms and industries in the years ahead.
The speaker session will be followed by a question and answer session with the audience. A networking session follows after the talk.
- Alexis Bernard, CTO, Hubbell, Inc.
- Carmine Lizza, MD, CIO and Global Head of Technology, Lazard
- Tsvi Gal, Memorial Sloan Kettering Cancer Center
- John McGill, CTO, Biohaven Pharmaceuticals
Alexis Bernard, PhD
Alexis Bernard has joined Hubbell Incorporated as its new Chief Technology Officer (CTO). In this newly created position, Alexis will lead the Company’s efforts to accelerate technical innovation and growth across all groups, including the expansion of existing product lines and new product development. He will also lead a cross-functional effort to identify and implement process improvements. Alexis will report to President & CEO, Hubbell Incorporated and will be based in the Shelton, CT office.
Alexis’ most recent role was CTO for Knowles Corporation, a $1 billion global supplier of advanced micro-acoustic, specialty components and human interface solutions in the mobile communications, consumer electronics, medical technology, military/space and other industrial end markets. Previously, he served in technology and corporate strategy roles with industry-leading technology companies such as Audience, Nokia and Texas Instruments. In addition to beginning his career as a research scientist and engineer, Alexis spent five years at McKinsey & Company in the firm’s telecom, media and technology practice in New York.
Carmine Lizza is a Managing Director and Chief Information Officer/Global Head of Technology for Lazard. His responsibilities include all aspects of technology that support Lazard’s global businesses and operations. Prior to joining Lazard, Carmine was a Managing Director at Bankers Trust, holding a number of senior technology and business management positions in their Institutional Services and Global Markets businesses. Prior to that, he was Head of Equity Systems and Operations at Alliance Capital Management. Carmine started his career at Lear Siegler Avionics, where he was responsible for designing software and testing equipment for military avionic systems.
Carmine is also a member of the Stevens Institute of Technology’s Business School Advisory Board, a 2021 member of the New York CIO Advisory Board and a 2020 New York CIO of the Year ORBIE Award Finalist in the Global CIO category.
Carmine has an MBA from Columbia University and a BE in Electrical Engineering and Computer Science from Stevens Institute of Technology.
Memorial Sloan Kettering Cancer Center (MSK) has appointed Tsvi Gal as Head of Infrastructure, effective April 2020. In this role, Mr. Gal will set the technical vision and lead the company’s technological development in support of the digital strategy and make technical recommendations that align with MKS goals.
A recipient of the Einstein Award for Technology and Science from the President of Israel for pioneering on-line banking and trading, Tsvi’s career spans over three decades.
Tsvi joins MSK from Morgan Stanley where he served in numerous roles including CTO of Enterprise Services, Head of Strategy & Architecture and others. Since he joined in early 2012, Tsvi was responsible for the creation and implementation of Morgan Stanley’s multi-year strategy and target state architecture and the evolution of the bank into a modern, efficient and effective organization.
Prior to Morgan Stanley Tsvi’s served in various CIO and CTO in several banks including Merrill Lynch/Bank of America, Deutsche Bank and Wells Fargo as well as in non-banks including Exigen Capital (a private equity firm) where he was a General Partner, AT&T where he was President of ATT.COM and Time Warner Music where, as CIO, he led the launch of the digital transformation towards on-line music.
John McGill is an innovative IT Leader with extensive global experience over 25 years building new IT capabilities to deliver business transformation. A strong and collaborative relationship builder, he brings passion and proven experience to all levels of both business and IT. Prior to joining Biohaven Pharmaceuticals he was SVP and CIO at Catalent Pharma Solutions; He also worked at Staples, Hoffman La Roche, Altria and has extensive hands-on experience with M&A, Digital Transformation, Cyber Security, IT Architecture and Governance, Business Relationship Management and Technology support.
He excels at building and leading global information technology organizations, balancing financial and vendor management, business relationship management, PMO leadership, and IT sourcing/outsourcing. He leads his teams to drive performance and efficiency, improve costs, support growth, and consistently exceed goals.